Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Early Stage and Discovery Deals: Strategy, Structure and Payment Terms' returned 4 results - Page 1 of 1   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Early Stage and Discovery Deals: Strategy, Structure and Payment Terms, 2nd Edition   Pharmalicensing Ltd., Dec 2006, Pages: 144 and Discovery Deals: Strategy, Structure and Payment Terms” analyzes early stage dealmaking trends and discusses the basics of dealmaking structures, covering payment terms and deal valuations. Updated with new Pharmaceutical Licensing Overview   Datamonitor, March 2010, Pages: 114 to share development risk How far can Big Pharma take its cost-cutting strategies? Big Pharma's near-term focus Late-and mid-stage deal activity set to increase as Pharma looks to offset the patent cliff The Top 10 Contract Research Organizations: Positioning, Performance and SWOT Analyses   Business Insights, March 2009, Pages: 168 Performance by business segments 129 Growth strategies 129 Global expansion of capacity 129 Early-stage expansion 129 Late-stage expansion 130 Investment in technology 130 Acquisitions and divestments 130 SWOT Biomarker Technology Platforms for Cancer Diagnoses and Therapies   TriMark Publications, Sep 2011, Pages: 343 . In the major solid cancer types such as lung, breast, colon and prostate, long-term survival rates drop precipitously once metastatis has occurred. The case is clear for development of biomarkers for early Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network